首页> 外文OA文献 >Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody

【2h】

Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody

机译：肿瘤内注射经遗传修饰以表达白介素12的骨髓源性树突状细胞与抗CTLA-4抗体联合诱导全身和治疗性抗肿瘤免疫

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody [J] . Marimo Sato-Matsushita, Yoshihiro Hayakawa, Asuka Asami, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：肿瘤内注射经遗传修饰以表达白介素12的骨髓源性树突状细胞与抗CTLA-4抗体联合诱导全身和治疗性抗肿瘤免疫
2. Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12. [J] . Yamanaka R, Tsuchiya N, Yajima N, Journal of neurosurgery. . 2003,第4期

机译：通过肿瘤内注射经基因工程化的Semliki Forest病毒脉冲刺激的树突状细胞来诱导抗肿瘤免疫反应，以产生白介素-18，并与白介素-12的全身性给药相结合。
3. Induction of ErbB-2eu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12. [J] . Chen Y, Emtage P, Zhu Q, Gene therapy . 2001,第4期

机译：使用转基因树突状细胞诱导ErbB-2 / neu特异性保护性和治疗性抗肿瘤免疫力：通过共转导编码IL-12的基因提高疗效。
4. AT1412: A Patient-Derived Antibody Targeting the Tetraspanin CD9 Inhibits Tumor Progression by Stimulating the Influx of Immune Cells [C] . Koen Wagner, Remko Schotte, Els Verdegaal, Protein Engineering Summit. . 2018

机译：AT1412：靶向Tetraspanin CD9的患者衍生的抗体通过刺激免疫细胞的膨胀来抑制肿瘤进展
5. Genetically Stable Poliovirus Vectors Activate Dendritic Cells and Prime Antitumor CD8 T Cell Immunity [D] . Mosaheb, Mohammad Mubeen. 2019

机译：基因稳定的脊髓灰质血病毒载体激活树突细胞和抗肿瘤CD8 T细胞免疫力
6. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody [O] . Marimo Sato-Matsushita, Yoshihiro Hayakawa, Asuka Asami, 2015

机译：肿瘤内注射经遗传修饰以表达白介素12的骨髓源性树突状细胞与抗CTLA-4抗体联合诱导全身和治疗性抗肿瘤免疫
7. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas [O] . Melero, I. (Ignacio), Duarte, M. (Marina), Ruiz, J. (Juan), 1999

机译：肿瘤内注射经工程改造以产生白介素12的骨髓来源的树突状细胞可诱导已建立的鼠可移植结肠腺癌的完全消退

Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody

著录项

引文网络

相似文献

相关主题

期刊订阅